Thomas Neylan is a Psychiatry physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4150 Clement St
Vamc 116p
San Francisco, CA 941211545
Telephone
415-750-6961Registry record last updated 8 Jul 2007.
Clinical trials
- Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)
Sponsor: VA Office of Research and Development
- Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)
Sponsor: University of California, San Francisco
- Improving Mind/Body Health and Functioning With Integrative Exercise
Sponsor: VA Office of Research and Development
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Orion CorporationProgram year20251 payment
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20251 payment
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20248 payments$12,705openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
14 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP
University of California, San Francisco
FY2026$1,420,809R01AG060477 - Investigating Fear System Myelination in PTSD Using In Vivo and Post Mortem Data
Northern California Institute/res/edu
FY2026$1,310,852RF1MH132617 - Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment ofVeterans with Posttraumatic Stress Disorder (PTSD)
Veterans Affairs Med Ctr San Francisco
FY2026I01CX001917
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”